Search for: "Matter of Noonan"
Results 41 - 60
of 304
Sort by Relevance
|
Sort by Date
6 Nov 2021, 9:19 pm
In the webinar, entitled "Accepting the Status Quo: Subject Matter Eligibility Nearly a Decade after Mayo," Kevin Noonan and Donald Zuhn Jr. of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Cara Coburn of Genentech, June Cohan of the U.S. [read post]
10 Jun 2021, 4:05 pm
Matter of Noonan, 17 B.R. 793, 800 (Bankr. [read post]
20 May 2021, 9:14 pm
The matter arose when Pacific Biosciences asserted U.S. [read post]
3 May 2021, 9:59 pm
It is an application of the Federal Circuit's fractured jurisprudence on subject matter eligibility under 35 U.S.C. [read post]
26 Apr 2021, 9:11 pm
Noonan -- Demagogy is never pretty. [read post]
28 Mar 2021, 9:24 pm
Noonan -- Exactly two weeks after affirming a decision by the U.S. [read post]
14 Mar 2021, 9:07 pm
Noonan -- The Federal Circuit affirmed a decision by the U.S. [read post]
13 Mar 2021, 8:05 pm
In this presentation, MBHB attorney and Patent Docs author Kevin Noonan and MBHB attorney and Patent Docs contributor Bryan Helwig will discuss the following patent and IP law related topics: • Basics of virology and vaccines • SARS-CoV-2 (COVID) • Vaccines generally • COVID vaccines in development • Patent matters • Patent Licensing (compulsory and otherwise) • Vaccine availability and accessibility • Politics • Future prospects… [read post]
9 Mar 2021, 9:21 pm
Noonan -- Senator Thom Tillis (R-NC) has been busy letter writing lately (see "Sen. [read post]
4 Mar 2021, 8:06 pm
Noonan -- On March 1st, the U.S. [read post]
6 Jan 2021, 8:17 pm
Noonan -- Indefiniteness under U.S. patent law is a failure to satisfy the statutory requirements of 35 U.S.C. [read post]
25 Oct 2020, 9:44 pm
Noonan -- One of the most interesting (albeit troubling) decisions by the Federal Circuit in the past year or so was its decisions, by a panel and then in denying review en banc, in American Axle & Manufacturing, Inc. v. [read post]
22 Oct 2020, 9:48 pm
The matter arose in two inter partes review proceedings, wherein St. [read post]
12 Oct 2020, 9:59 pm
The Commission has not lost its enthusiasm for such interventions in drug patenting matters but without (so far) overwhelming success. [read post]
13 Sep 2020, 9:59 pm
Noonan, Ph.D., Patent Docs (Aug. 24, 2020). [read post]
1 Sep 2020, 9:59 pm
Noonan -- The Federal Circuit recently applied well-established principles of obviousness in affirming the Patent Trial and Appeals Board's invalidation of several patents related to antifungal formulations in Anacor Pharmaceuticals, Inc. v. [read post]
31 Aug 2020, 2:36 pm
It is not a matter of if, but when. [read post]
24 Aug 2020, 9:50 pm
Noonan -- The Federal Circuit's inchoate attempts to fashion a consistent, rational application of the Supreme Court's recent subject matter eligibility jurisprudence, while understandably Herculean in view of the difficulties inherent in that precedent, raises questions regarding the value of having a "specialized" Circuit Court for the purpose of harmonizing U.S. patent law (see "The Proper Role of the Federal Circuit"; "In Defense of the… [read post]
13 Aug 2020, 1:55 am
But a remote employee’s work theoretically could be performed in the employer’s state, no matter how inconvenient or even impossible that might be for a given employee. [read post]
9 Aug 2020, 9:37 pm
The Court followed this practice in what is perhaps its most confusing and controversial application of the Supreme Court's subject matter eligibility jurisprudence under Alice Corp. [read post]
